ES2109225T3 - Anticuerpos, su produccion y uso. - Google Patents

Anticuerpos, su produccion y uso.

Info

Publication number
ES2109225T3
ES2109225T3 ES90116234T ES90116234T ES2109225T3 ES 2109225 T3 ES2109225 T3 ES 2109225T3 ES 90116234 T ES90116234 T ES 90116234T ES 90116234 T ES90116234 T ES 90116234T ES 2109225 T3 ES2109225 T3 ES 2109225T3
Authority
ES
Spain
Prior art keywords
polypeptide
antibody
formula
acid sequence
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90116234T
Other languages
English (en)
Inventor
Kazuo Nakahama
Tsunehiko Fukuda
Tsutomu Kurokawa
Ken-Ichi Kuroshima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ES2109225T3 publication Critical patent/ES2109225T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C07K14/625—Extraction from natural sources
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE MUESTRA (A) UN ANTICUERPO PEPTIDO QUE INCLUYE AL MENOS OCHO AMINOACIDOS SUCESIVAMENTE, DE UN ACIDO REPRESENTADO CONSECUTIVAMENTE POR FORMULA (1): **FORMULA** (B) UN METODO PARA PRODUCIR ANTICUERPOS, (C) UN CLONE HIBRIDO QUE PRODUCE EL ANTICUERPO, (D) UN METODO PARA PRODUCIR UN CLONE HIBRIDO,(E) UN PETIDO DE UN POLIPEPTIDO (1) INCLUYENDO UN AMINOACIDO REPRESENTADO CONSECUTIVAMENTE POR FORMULA (1), (F) UN PEPTIDO ENLAZADO, QUE LLEVA AL MENOS OCHO AMINOACIDOS SUCESIVAMENTE DE FORMULA (1), CON UNA PROTEINA PORTADORA (G) Y UN METODO PARA PURIFICACION DEL POLIPEPTIDO (1) Y (H) UN METODO PARA DETECTAR Y ENSAYAR EL POLIPEPTIDO
ES90116234T 1989-08-28 1990-08-24 Anticuerpos, su produccion y uso. Expired - Lifetime ES2109225T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21871189 1989-08-28
JP13405890 1990-05-25

Publications (1)

Publication Number Publication Date
ES2109225T3 true ES2109225T3 (es) 1998-01-16

Family

ID=26468244

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90116234T Expired - Lifetime ES2109225T3 (es) 1989-08-28 1990-08-24 Anticuerpos, su produccion y uso.

Country Status (7)

Country Link
EP (1) EP0418590B1 (es)
AT (1) ATE160288T1 (es)
CA (1) CA2024063C (es)
DE (1) DE69031726T2 (es)
DK (1) DK0418590T3 (es)
ES (1) ES2109225T3 (es)
GR (1) GR3025835T3 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1243281B (it) * 1990-06-12 1994-05-26 Fidia Spa Metodo per la determinazione quantitativa e qualitativa di polipeptidiin liquidi proteici
US5958875A (en) * 1996-03-29 1999-09-28 The Regents Of The University Of California Synthetic peptides derivatives with nerve growth factor-like neurotrophic activity
EP1556083B1 (en) 2002-10-08 2011-02-02 Rinat Neuroscience Corp. Methods for treating post-surgical pain by admisnistering an antibody against nerve growth factor and compositions containing the same
US7255860B2 (en) 2002-10-08 2007-08-14 Rinat Neuroscience Corp. Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody
EP2270048B1 (en) 2002-12-24 2015-11-11 Rinat Neuroscience Corp. Anti-NGF antibodies and methods using same
US9498530B2 (en) 2002-12-24 2016-11-22 Rinat Neuroscience Corp. Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
US7569364B2 (en) 2002-12-24 2009-08-04 Pfizer Inc. Anti-NGF antibodies and methods using same
KR20050111598A (ko) 2003-02-19 2005-11-25 리나트 뉴로사이언스 코퍼레이션 신경 성장 인자 길항제 및 ｎｓａｉｄ를 투여함으로써통증을 치료하는 방법 및 그것을 함유하는 조성물
MEP31508A (hr) 2003-07-15 2010-10-10 Amgen Inc Humana anti-ngf neutrališuća antitijela kao selektivni ihibitori ngf signalne kaskade
AU2005243247B2 (en) 2004-04-07 2012-03-01 Regents Of The University Of Minnesota Methods for treating bone cancer pain by administering a nerve growth factor antagonist
ME00226B (me) 2004-07-15 2011-02-10 Medarex Llc Humana anti-ngf neutrališuća antitijela kao selektivni inhibitori ngf signalne kaskade
WO2010079850A2 (en) 2009-01-12 2010-07-15 Takeda Pharmaceutical Company Limited Agent for prophylaxis or treatment of cancer

Also Published As

Publication number Publication date
JPH04128298A (ja) 1992-04-28
CA2024063A1 (en) 1991-03-01
EP0418590A1 (en) 1991-03-27
GR3025835T3 (en) 1998-04-30
CA2024063C (en) 2002-07-16
DK0418590T3 (da) 1998-04-20
DE69031726D1 (de) 1998-01-02
EP0418590B1 (en) 1997-11-19
ATE160288T1 (de) 1997-12-15
DE69031726T2 (de) 1998-03-12

Similar Documents

Publication Publication Date Title
ATE88572T1 (de) Antikoerper gegen polypeptide, die gegen peptide oder proteine mit mindestens teilweise bekannter aminosaeure oder kodierender nukleotidsequenz komplementaer sind und diesbezuegliches aufbauverfahren.
AU564620B2 (en) Peptides and protein-peptide complexes
LU91013I2 (fr) ReFacto (Moroctocog alfa) dans toutes ses formes couvertes par le brevet de base
DK0418590T3 (da) Antistoffer, fremstilling deraf og anvendelse deraf
BG60017B2 (bg) Метод за намаляване хетерогенността на моноклонални антитела
ATE68826T1 (de) Verfahren zur herstellung von reifem, menschlichem serum-albumin.
EP0869177A3 (en) Human a- and b- platelet-derived growth factor receptor proteins and uses therefor.
KR900012626A (ko) 하이브리드 단백질, 이의 생산방법 및 이를 함유하는 약제학적 조성물
EP0741869A1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
NO850087L (no) Bestemmelse av fibrin med fibrin-spesifikke antistoffer
ATE326483T1 (de) Reagenzien für die diagnose von rheumatoiden arthritis
ATE133422T1 (de) Peptide und deren benutzung
KR890012669A (ko) 심방 나트륨이뇨성 폴리펩티드를 인지하는 단일클론성 항체
JPS5767858A (en) Immunochemical measurement method for human chorionic gonadotropin and production of antibody
Yanaihara et al. Synthesis of proinsulin. III. Synthesis of polypeptides related to the connecting peptide segment of bovine proinsulin
NO904129D0 (no) Antistoffer mot hoeykonserverte aminosyresekvenser fra immunogene forbindelser, fremgangsmaate for fremstilling av antistoffer samt anvendelse derav i immunoanalyser.
ATE110853T1 (de) Immuntestverfahren für zelluläres eiweiss.
ATE88639T1 (de) Antigenisches peptid der 28kd proteingruppe aus s. mansoni und sein verfahren zur isolierung, monoklonale antikoerper, die mindestens ein epitop dieses peptids erkennen und verwendungen fuer die induzierung der synthese von neutralisierenden antikoerpern.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 418590

Country of ref document: ES